Enfusion Inc (ENFN) Actualités

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 4 - Statement of changes in beneficial ownership of securities

クリアウォーター・アナリティクスがエンフュージョンを15億ドルで買収、フロントからバックまで対応可能な投資管理プラットフォームを提供

1月13日午前8時30分（東部標準時）に投資家向けカンファレンス・コールを実施 （ビジネスワイヤ） -- クリアウォーター・アナリティクス（NYSE：CWAN、「...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc. PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 144 - Report of proposed sale of securities

Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities